SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-18-005230
Filing Date
2018-11-05
Accepted
2018-11-05 14:23:15
Documents
44
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm 10-Q 157219
2 CERTIFICATION nbio_ex311.htm EX-31.1 7638
3 CERTIFICATION nbio_ex312.htm EX-31.2 7671
4 CERTIFICATION nbio_ex321.htm EX-32.1 3119
5 CERTIFICATION nbio_ex322.htm EX-32.2 3151
  Complete submission text file 0001477932-18-005230.txt   1517801

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20180930.xml EX-101.INS 223476
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20180930.xsd EX-101.SCH 30325
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20180930_cal.xml EX-101.CAL 25168
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20180930_def.xml EX-101.DEF 93829
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20180930_lab.xml EX-101.LAB 140770
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20180930_pre.xml EX-101.PRE 139110
Mailing Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 181159633
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences